Clinical trials
Infarction clinical trials
Below are recruiting infarction clinical trials, each written for real people, not researchers. We’re tracking 397 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07771335Recruiting
Erlangen stroke registry: tracking strokes over time
This study collects health information from people in Erlangen, Germany who have had a stroke. It helps researchers understand stroke causes and outcomes to improve future care.
ErlangenAges 18 years+ - NCT05685069Recruiting
Studying stroke risk factors in people with silent brain infarcts
This study looks for what may have caused “silent” mini-strokes in the brain that were found on MRI, and which risk factors might be changeable. It may help doctors better understand how to prevent future stroke in people who have no clear stroke symptoms from the finding.
ToursAges 16 years+ - NCT07567625Recruiting
Heart Attack Treatment Without a Stent
This trial tests whether patients who have had a heart attack with a specific type of artery blockage can be safely treated without placing a metal stent (tube) in their artery. Doctors will monitor whether the blockage stays open on its own.
Harbin, HeilongjiangAges 18–75 - NCT06994221Recruiting
Heart function study after heart attack with aneurysm
This trial looks at how heart scarring after a major heart attack affects the heart's shape and function. It might help people who developed a bulge (aneurysm) in the heart wall after their attack.
ShanghaiAges 18–75 - NCT06710184RecruitingPhase 4
Aspirin alone vs. aspirin plus fondaparinux before early heart catheterization in NSTEMI
This study tests whether taking aspirin alone works as well as aspirin plus a blood thinner called fondaparinux before a heart procedure in people with a specific type of heart attack (NSTEMI). It aims to find the safest and most effective treatment before an early heart catheterization.
Herning, Region MidtAges 18 years+ - NCT04899479RecruitingPhase 4
SGLT-2 inhibitor after heart attack to improve heart recovery
This trial studies whether starting an SGLT-2 inhibitor around the time of a heart attack can reduce heart damage size and improve how the heart heals. It focuses on people with a high risk of developing heart failure and who are getting a procedure to open blocked heart arteries.
SeoulAges 18 years+ - NCT05198791RecruitingPhase 2
Eplerenone for heart injury without blocked heart arteries
This Phase 2 study tests whether eplerenone can improve outcomes after a heart attack (or similar heart injury) when coronary angiography shows no blocked heart arteries. It focuses on people with added cardiovascular risk factors and evaluates how well the treatment works for heart recovery and strain on the heart.
East Kilbride, LanarkshireAges 18 years+ - NCT05431296Recruiting
Glucose monitoring after a heart attack in type 2 diabetes
This study tests a way of checking blood sugar closely after an acute coronary event (a heart-related emergency) in people with type 2 diabetes. It may help doctors understand the best monitoring approach to improve safety and care during recovery.
LondonAges 18 years+ - NCT05812963Recruiting
IVUS vs FFR to guide stents after heart attacks
This trial compares two ways of measuring blood flow inside the heart arteries (IVUS vs FFR) to help decide which non–culprit artery narrowings need a stent after a recent heart attack. It may help doctors choose the best targets for PCI and avoid unnecessary procedures.
GwangjuAges 19 years+ - NCT06040528Recruiting
Early discharge after heart attack: a registry study
This study looks at patients who go home early after a heart attack. It collects information to see how safe and effective early discharge is.
LondonAges 16 years+ - NCT06227754Recruiting
OCT vs. angiography for heart attack treatment
This trial compares two ways to guide treatment during a heart attack: using a special camera (OCT) inside the artery or standard X-ray (angiography). It aims to see which method leads to better results for patients.
Daegu, DaeguAges 19 years+ - NCT06567249Recruiting
Cooling the heart during a heart attack procedure
This study tests whether cooling the heart with a cold liquid during a procedure (angioplasty) can help reduce damage after a heart attack. It may be an option for people who arrive at the hospital quickly after a heart attack.
TomskAges 18–90 - NCT07008391Recruiting
High-sensitivity troponin test in ambulance care
This trial tests whether using a high-sensitivity troponin I test in the ambulance, along with standard care, can help emergency medical services better identify heart attacks. This might lead to faster treatment for patients with chest pain or suspected heart attack.
Stockholm, ÅrstaAges 18 years+ - NCT07027891Recruiting
AI ECG test to rule out heart attack in chest pain patients
This study tests if an AI tool reading your ECG can quickly rule out a heart attack in people with chest pain. If you're having chest pain that might be a heart attack, but it's not a severe STEMI type, you may be able to join.
SeoulAges 18 years+ - NCT07436429Recruiting
Drug-coated balloon for heart attack treatment
This trial tests if a special balloon that releases medication can be used instead of a stent during emergency angioplasty for certain heart attacks. It may help patients who are having a first-time heart attack and are stable enough for the procedure.
ViennaAges 18 years+ - NCT06690684Enrolling by invitation
Finding new blood markers for heart disease
This study is looking for people who have had a heart attack or have heart failure to discover new markers in your blood that could help doctors better understand and treat heart disease. By collecting samples and health data, researchers hope to find clues that improve care for future patients.
Shanghai, Jing 'an DistrictAges 30 years+ - NCT07655479Recruiting
Switching to a stronger heart pump after heart attack
This trial tests whether switching to a more powerful heart pump (Impella 5.5) within 24 hours of a heart attack helps people whose hearts are still struggling despite a standard pump. It may be an option for patients who had a heart attack, received an Impella CP pump, but still need strong medication to keep blood flowing.
Düsseldorf, North Rhine-WestphaliaAges 18–77 - NCT07780942Recruiting
Testing a smartwatch for detecting heart attacks in people with chest pain
This study is testing how well a smartwatch can detect a specific type of heart attack (STEMI) in people who come to the hospital with chest pain. It aims to see if the smartwatch's ECG feature is accurate compared to standard hospital tests.
Cartagena, MurciaAges 18 years+ - NCT07587294Recruiting
Ultrasound Treatment to Prevent Heart Rhythm Problems After Heart Attack
This trial tests whether a special ultrasound procedure on the side of your neck can help prevent dangerous irregular heartbeats in patients who recently had a heart attack treated with a stent. The goal is to see if this treatment is safe and effective.
Huangshi, HubeiAges 18–80 - NCT07764588Recruiting
Immune cell study after a heart attack
This study looks at how immune cells change in the first few hours after a severe heart attack (STEMI) and how that relates to early scar healing. It may help doctors understand why some patients heal better than others.
ShanghaiAges 18–80 - NCT06209723Recruiting
Vegetarian diet study for recent heart attack patients and their partners
This study tests whether a vegetarian diet can help the immune system recover after a heart attack. It is for people who recently had a heart attack and their healthy partners.
NijmegenAges 18 years+ - NCT05211401RecruitingPhase 2
Testing rituximab for heart attack patients
This study tests whether adding the drug rituximab to standard heart attack treatment can reduce damage to the heart muscle after a heart attack. Rituximab is usually used for immune system conditions, and it may help calm inflammation and protect the heart. Participants must have a certain type of heart attack and be treated quickly.
ParisAges 18 years+ - NCT06566625Recruiting
MRI before heart catheterization for heart attack
This trial compares using a cardiac MRI before the standard catheterization (angiogram) in people with a suspected heart attack that doesn't show the typical ECG changes. It aims to see if the MRI can help guide decisions and avoid unnecessary procedures.
Stockholm, SwedenAges 18 years+ - NCT06836531Enrolling by invitation
Quick blood test for heart attack drug levels
This trial is testing a new way to quickly measure the level of a blood thinner (tirofiban) in the blood of people having a heart attack. It aims to make sure the dose is right and safe for each patient.
Ningbo, ZhejiangAges 18–75
Hear when a new Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infarction?
- Yes. Clin2 currently lists 397 recruiting infarction studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infarction trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infarction trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.